Chiari R - Search Results

1

Texture Analysis on [¹⁸F]FDG PET/CT in Non-Small-Cell Lung Cancer: Correlations Between PET Features, CT Features, and Histological Types.

Bianconi F, Palumbo I, Fravolini ML, Chiari R, Minestrini M, Brunese L, Palumbo B. Bianconi F, et al. Among authors: chiari r. Mol Imaging Biol. 2019 Dec;21(6):1200-1209. doi: 10.1007/s11307-019-01336-3. Mol Imaging Biol. 2019. PMID: 30847822

2

Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations.

Ludovini V, Bianconi F, Pistola L, Pistola V, Chiari R, Colella R, Bellezza G, Tofanetti FR, Siggillino A, Baldelli E, Flacco A, Giuffrida D, Sidoni A, Crinò L. Ludovini V, et al. Among authors: chiari r. Cancer Chemother Pharmacol. 2012 May;69(5):1289-99. doi: 10.1007/s00280-012-1829-7. Cancer Chemother Pharmacol. 2012. PMID: 22302407

3

Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.

Ludovini V, Flacco A, Bianconi F, Ragusa M, Vannucci J, Bellezza G, Chiari R, Minotti V, Pistola L, Tofanetti FR, Siggillino A, Baldelli E, Sidoni A, Daddi N, Puma F, Varella-Garcia M, Crinò L. Ludovini V, et al. Among authors: chiari r. Cancer Chemother Pharmacol. 2013 Mar;71(3):671-80. doi: 10.1007/s00280-012-2056-y. Epub 2013 Jan 12. Cancer Chemother Pharmacol. 2013. PMID: 23314677 Free PMC article.

4

Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer.

Metro G, Chiari R, Baldi A, De Angelis V, Minotti V, Crinò L. Metro G, et al. Among authors: chiari r. Future Oncol. 2013 Feb;9(2):167-77. doi: 10.2217/fon.12.198. Future Oncol. 2013. PMID: 23414467

5

How might treatment of ALK-positive non-small cell lung cancer change in the near future?

Metro G, Bellezza G, Puma F, Chiari R. Metro G, et al. Among authors: chiari r. Expert Rev Anticancer Ther. 2016 Oct;16(10):997-9. doi: 10.1080/14737140.2016.1226138. Epub 2016 Aug 25. Expert Rev Anticancer Ther. 2016. PMID: 27534579 No abstract available.

6

The safety of nivolumab for the treatment of advanced non-small cell lung cancer.

Metro G, Ricciuti B, Brambilla M, Baglivo S, Soli I, Minenza E, Leonardi GC, D'arpino A, Colabrese D, Tazza M, Zicari D, Minotti V, Chiari R. Metro G, et al. Among authors: chiari r. Expert Opin Drug Saf. 2017 Jan;16(1):101-109. doi: 10.1080/14740338.2017.1267725. Epub 2016 Dec 11. Expert Opin Drug Saf. 2017. PMID: 27910704 Review.

7

Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?

De Giglio A, Porreca R, Brambilla M, Metro G, Prosperi E, Bellezza G, Pirro M, Chiari R, Ricciuti B. De Giglio A, et al. Among authors: chiari r. Thromb Res. 2018 Mar;163:51-53. doi: 10.1016/j.thromres.2017.12.004. Epub 2017 Dec 9. Thromb Res. 2018. PMID: 29353684 No abstract available.

8

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience.

Ricciuti B, Baglivo S, De Giglio A, Chiari R. Ricciuti B, et al. Among authors: chiari r. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808659. doi: 10.1177/1753466618808659. Ther Adv Respir Dis. 2018. PMID: 30355049 Free PMC article. Review.

9

Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool.

Mandarano M, Bellezza G, Belladonna ML, Vannucci J, Gili A, Ferri I, Lupi C, Ludovini V, Falabella G, Metro G, Mondanelli G, Chiari R, Cagini L, Stracci F, Roila F, Puma F, Volpi C, Sidoni A. Mandarano M, et al. Among authors: chiari r. Front Immunol. 2020 May 27;11:839. doi: 10.3389/fimmu.2020.00839. eCollection 2020. Front Immunol. 2020. PMID: 32536910 Free PMC article.

10

Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.

Mandarano M, Orecchini E, Bellezza G, Vannucci J, Ludovini V, Baglivo S, Tofanetti FR, Chiari R, Loreti E, Puma F, Sidoni A, Belladonna ML. Mandarano M, et al. Among authors: chiari r. Int J Mol Sci. 2021 Apr 22;22(9):4403. doi: 10.3390/ijms22094403. Int J Mol Sci. 2021. PMID: 33922388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters